Agios Pharm (AGIO) — Cash Flow Quality Index
Agios Pharm (AGIO) has a Cash Flow Quality Index of -0.09x as of September 2024. Operating cash flow of $-84.22 Million is below net income of $947.91 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Agios Pharm operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Agios Pharm Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Agios Pharm across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Agios Pharm cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Agios Pharm (2024–2024)
Year-by-year earnings quality comparison for Agios Pharm. For live market cap and the full company financial profile, see AGIO market cap overview.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.58x | $-389.84 Million | $673.73 Million | — |